Nuclear genetic defects of oxidative phosphorylation.

ATP generated by oxidative phosphorylation is necessary for the normal function of most cells in the body. Partial deficiencies in this system are an important cause of a large and diverse group of multisystem disorders. As both the nuclear and mitochondrial genomes encode structural components of the enzyme complexes of the oxidative phosphorylation system, the disorders can be transmitted either in a Mendelian fashion or maternally, or can occur as sporadic cases. Over the last 12 years more than 100 mutations have been uncovered in mtDNA, mostly associated with disease in the adult population. Recently, much attention has turned to the investigation of the nuclear oxidative phosphorylation gene defects. The majority of these are inherited as autosomal recessive traits, producing severe, and usually fatal disease in infants. Adult-onset Mendelian oxidative phosphorylation diseases, which can be inherited as autosomal recessive or dominant traits, have a milder phenotype, and most are associated with multiple mtDNA deletions. Approximately 20 different nuclear gene defects have now been identified in genes coding for structural components of the complexes, assembly/maintenance factors and factors necessary for the maintenance of mtDNA integrity. Some clear genotype-phenotype associations have emerged, and there is an unexpected link between some structural gene mutations and rare cancers, implicating mitochondria as oxygen sensors in the hypoxia response.

[1]  S. Dimauro,et al.  An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region , 1989, Nature.

[2]  A. Harding,et al.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. , 1990, American journal of human genetics.

[3]  C. Dieckmann,et al.  PET genes of Saccharomyces cerevisiae. , 1990, Microbiological reviews.

[4]  J. Christodoulou,et al.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. , 1992, American journal of human genetics.

[5]  L. Peltonen,et al.  An autosomal locus predisposing to deletions of mitochondrial DNA , 1995, Nature Genetics.

[6]  Thomas Bourgeron,et al.  Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency , 1995, Nature Genetics.

[7]  Rappold,et al.  Human Molecular Genetics , 1996, Nature Medicine.

[8]  S. Dimauro,et al.  Multiple mitochondria1 DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy , 1996, Neurology.

[9]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[10]  D. Turnbull,et al.  Molecular analysis of cytochromec Oxidase deficiency in Leigh's syndrome , 1997, Annals of neurology.

[11]  J. Lonnqvist,et al.  Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA , 1997, Neurology.

[12]  D. Glerum,et al.  SHY1, the Yeast Homolog of the MammalianSURF-1 Gene, Encodes a Mitochondrial Protein Required for Respiration* , 1997, The Journal of Biological Chemistry.

[13]  E. Shoubridge,et al.  SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome , 1998, Nature Genetics.

[14]  B. Robinson Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. , 1998, Biochimica et biophysica acta.

[15]  B. Hamel,et al.  The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. , 1998, American journal of human genetics.

[16]  T. Meitinger,et al.  A systematic mutation screen of 10 nuclear and 25 mitochondrial candidate genes in 21 patients with cytochrome c oxidase (COX) deficiency shows tRNA(Ser)(UCN) mutations in a subgroup with syndromal encephalopathy. , 1998, Journal of medical genetics.

[17]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[18]  E. Bertini,et al.  Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. , 1998, American journal of human genetics.

[19]  J. Skehel,et al.  NADH:ubiquinone oxidoreductase from bovine heart mitochondria: sequence of a novel 17.2‐kDa subunit , 1998, FEBS letters.

[20]  E. Mariman,et al.  Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. , 1998, American journal of human genetics.

[21]  D. Weeks,et al.  Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. , 1998, American journal of human genetics.

[22]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[23]  S. Merchant,et al.  Human deafness dystonia syndrome is a mitochondrial disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Kaplan,et al.  Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene , 1999, Nature Genetics.

[25]  L. Peltonen,et al.  A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia. , 1999, American journal of human genetics.

[26]  G. Comi,et al.  Loss‐of‐function mutations of SURF‐1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency , 1999, Annals of neurology.

[27]  D. Thorburn,et al.  Respiratory chain complex I deficiency , 1999, Neurology.

[28]  H. Antonicka,et al.  A novel deficiency of mitochondrial ATPase of nuclear origin. , 1999, Human molecular genetics.

[29]  P. Barth,et al.  Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I , 1999, Annals of neurology.

[30]  S. Dimauro,et al.  Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. , 1999, The New England journal of medicine.

[31]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[32]  V. Tiranti,et al.  Characterization of SURF-1 expression and Surf-1p function in normal and disease conditions. , 1999, Human molecular genetics.

[33]  L. Grivell,et al.  Mitochondrial assembly in yeast , 1999, FEBS letters.

[34]  E. Mariman,et al.  Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy , 1999, Nature Genetics.

[35]  E. Shoubridge,et al.  Expression and functional analysis of SURF1 in Leigh syndrome patients with cytochrome c oxidase deficiency. , 1999, Human molecular genetics.

[36]  A. Munnich,et al.  A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. , 2000, Human molecular genetics.

[37]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[38]  E. Schon,et al.  A human SCO2 mutation helps define the role of Sco1p in the cytochrome oxidase assembly pathway. , 2000, The Journal of biological chemistry.

[39]  P. Kaplan,et al.  Differential features of patients with mutations in two COX assembly genes, SURF‐1 and SCO2 , 2000, Annals of neurology.

[40]  B. Robinson Human Cytochrome Oxidase Deficiency , 2000, Pediatric Research.

[41]  A. Munnich,et al.  Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. , 2000, American journal of human genetics.

[42]  E. Shoubridge,et al.  Characterization of human SCO1 and COX17 genes in mitochondrial cytochrome-c-oxidase deficiency. , 2000, Biochemical and biophysical research communications.

[43]  D. Turnbull,et al.  The epidemiology of pathogenic mitochondrial DNA mutations , 2000, Annals of neurology.

[44]  J. Grosgeorge,et al.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.

[45]  E. Shoubridge,et al.  Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency. , 2000, Human molecular genetics.

[46]  L. V. D. Heuvel,et al.  Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. , 2000, Biochemical and biophysical research communications.

[47]  L. P. Van den Heuvel,et al.  Isolated complex I deficiency in children: Clinical, biochemical and genetic aspects , 2000, Human mutation.

[48]  L. Peltonen,et al.  Role of adenine nucleotide translocator 1 in mtDNA maintenance. , 2000, Science.

[49]  S. Bhattacharya,et al.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.

[50]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[51]  C. Eng,et al.  Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.

[52]  D. Turnbull,et al.  Late‐onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene , 2000, Annals of neurology.

[53]  A. Munnich,et al.  Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome , 2000, Human Genetics.

[54]  V. Tiranti,et al.  Mutations in the SURF1 gene associated with Leigh syndrome and cytochrome c oxidase deficiency , 2001, Human mutation.

[55]  P. Ratcliffe,et al.  Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. , 2001, Human molecular genetics.

[56]  E. Shoubridge,et al.  Mutations in SURF1 are not specifically associated with Leigh syndrome , 2001, Journal of medical genetics.

[57]  Mutations in BCS1, a mitochondrial respiratory chain assembly gene, are responsible for complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. , 2001 .

[58]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.

[59]  M. Ivan,et al.  von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. , 2001, Human molecular genetics.

[60]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[61]  J. Smeitink,et al.  Respiratory chain complex I deficiency. , 2001, American journal of medical genetics.

[62]  E. Lander,et al.  A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16. , 2001, American journal of human genetics.

[63]  P. Bénit,et al.  Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. , 2001, American journal of human genetics.

[64]  P. Patel,et al.  Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency. , 2001, American journal of human genetics.

[65]  H. Mandel,et al.  Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy , 2001, Annals of neurology.

[66]  G. Comi,et al.  Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria , 2001, Nature Genetics.

[67]  W. K. Chong,et al.  A SURF1 gene mutation presenting as isolated leukodystrophy , 2001, Annals of neurology.

[68]  V. Petruzzella,et al.  A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome. , 2001, Human molecular genetics.

[69]  T. Hudson,et al.  A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. , 2001, American journal of human genetics.

[70]  D. Evans,et al.  Germline SDHD mutation in familial phaeochromocytoma , 2001, The Lancet.